11보유 구루
0.00%평균 비중
$0.0B총 보유액
0신규 진입
시세 차트
LYEL
LYEL차트 불러오는 중
스마트머니 스코어
보유 구루 (11)
13F 기준 · 비중 순| # | 투자자 | 비중 | 보유 주식 | 평가 금액 | 활동 |
|---|---|---|---|---|---|
| 1 |  이스라엘 잉글랜더 Millennium Management LLC | 0.00% | 458,905 | $9.21M | HOLD |
| 2 |  짐 사이먼스 (유산) Renaissance Technologies LLC | 0.00% | 116,411 | $2.34M | HOLD |
| 3 |  켄 그리핀 Citadel Advisors LLC | 0.00% | 381,462 | $7.65M | HOLD |
| 4 |  스티브 코헨 Point72 Asset Management LP | 0.00% | 21,292 | $427,118 | HOLD |
| 5 |  골드만삭스 Goldman Sachs Asset Management | 0.00% | 114,491 | $2.30M | HOLD |
| 6 |  데이비드 시겔 Two Sigma Investments LP | 0.00% | 11,585 | $232,395 | HOLD |
| 7 |  블랙록 BlackRock Inc | 0.00% | 191,820 | $3.85M | HOLD |
| 8 |  스테이트 스트리트 State Street Global Advisors | 0.00% | 72,522 | $1.45M | HOLD |
| 9 |  T. 로우 프라이스 T. Rowe Price Associates | 0.00% | 13,128 | $264,000 | HOLD |
| 10 |  피델리티 (FMR) Fidelity Management & Research | 0.00% | 1,823 | $36,569 | HOLD |
| 11 |  JP모건 체이스 JPMorgan Asset Management | 0.00% | 1,468 | $28,318 | HOLD |
내부자 거래 (14)
전체 보기| 내부자 | 직책 | 유형 | 주식 수 | 금액 | 일자 |
|---|---|---|---|---|---|
| Innovative Cellular Therapeutics Holdings Ltd | 10% Owner | BUY | 76,000 | -- | 2026. 6. 29. |
| Innovative Cellular Therapeutics Holdings Ltd | 10% Owner | BUY | 66,500 | -- | 2026. 6. 15. |
| Bulis Veronica Sanchez | VP, Corporate Controller | SELL | 217 | $0.0M | 2026. 5. 11. |
| Lee Gary K. | Chief Scientific Officer | SELL | 130 | $0.0M | 2026. 5. 11. |
| Hill Stephen J. | Chief Operating Officer | SELL | 89 | $0.0M | 2026. 5. 11. |
| Seely Lynn | President and CEO | SELL | 388 | $0.0M | 2026. 5. 11. |
| RIEFLIN WILLIAM JL | Director | BUY | 9,250 | $0.1M | 2026. 6. 10. |
| BRAWLEY OTIS W | Director | BUY | 9,250 | $0.1M | 2026. 6. 10. |
| Bachleda Mark | Director | BUY | 9,250 | $0.1M | 2026. 6. 10. |
| NABEL ELIZABETH G | Director | BUY | 9,250 | $0.1M | 2026. 6. 10. |